Paras Mehta
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
Present Title & Affiliation
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Postgraduate Training
| 2019-2022 | Clinical Fellowship, Endocrinology and Metabolism, University of California, San Francisco, California |
| 2015-2018 | Clinical Internship and Residency, Internal Medicine, Baylor College of Medicine, Houston, Texas |
Board Certifications
| 2021 | American Board of Internal Medicine: Endocrinology, Diabetes and Metabolism |
| 2018 | American Board of Internal Medicine: Internal Medicine |
Experience & Service
Other Appointments/Responsibilities
Endocrine EHR Officer, Faculty Representative, MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Institutional Committee Activities
Endocrine Department Representative, Medical Records, 2024 - Present
Member, Diabetes and Insulin Management, 2020 - 2023
Chief Fellow and Liaison, Endocrinology Fellowship Program Evaluation, 2020 - 2021
Member, Fellow Selection, 2019 - 2023
Member, Resident Selection, 2018 - 2019
Executive Board Chair, Academics, 2016 - 2018
Honors & Awards
| Distinguished Educator Certificate, Baylor College of Medicine | |
| Certificate in Quality and Safety, Institute for Healthcare Improvement | |
| Morning Report Faculty Contribution Award, Baylor College of Medicine | |
| Graduate Medical Education Morale Grant Awardee, University of California |
Selected Publications
Peer-Reviewed Articles
- Wu Y, Luke B, Mehta P, Wu X, Lee J, Yi Y, Okpechi S, Gause B, Sherman S, Ochoa A, Dmitrovsky E, Liu X. Glycemic Control in Diabetic Patients Improved Overall Lung Cancer Survival across Diverse Populations. JNCI Cancer Spectrum 8(5), 2024. e-Pub 2024. PMID: 39270065.
- Mehta P, Kohn M, Rov-Ikpah E, San Luis C, Johnson C, Lee G, Koliwad S, Rushakoff R. Novel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized Patients. Sage 18(3):541-548, 2024. e-Pub 2024. PMID: 38454631.
- Mehta, PB, Robinson, A, Burkhardt, D, Rushakoff, RJ. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors – Lessons From a Case Series and Strategies to Decrease Incidence. Endocrine Practice 28(9):884-888, 2022. e-Pub 2022. PMID: 35753675.
- Jahoor, F, Hsu, JW, Mehta, PB, Keene, KR, Gaba, R, Mulukutla, SN, Caducoy, E, Peacock, WF, Patel, SG, Bennet, R, Lernmark, A, Balasubramanyam, A. Metabolomics Profiling of Patients With A2b+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis. Diabetes 70(8):1898-1909, 2021. e-Pub 2021. PMID: 34021044.
- Mehta, PB, Kohn, MA, Koliwad, SK, Rushakoff, RJ. Lack of Association between Either Outpatient or Inpatient Glycemic Control and COVID-19 Illness Severity or Mortality in Patients With Diabetes. BMJ Open Diabetes Research and Care 9(1), 2021. e-Pub 2021. PMID: 34059527.
Editorials
- Mehta, PB, Gosmanov, AR. Inpatient Glycemic Control and Community-Acquired Pneumonia Outcomes in the Pre-COVID-19 Era. BMJ Open Diabetes Research and Care 10(4), 2022. PMID: 35790321.
Book Chapters
- Mehta P, Rov-Ikpah E, Rushakoff R. Chapter 3. In: Diabetes Management in Hospitalized Patients: A Comprehensive Clinical Guide. None. Springer, 39-48, 2024.
- Choi M, Mehta P, Rushakoff R. Chapter 10. In: Diabetes Management in Hospitalized Patients: A Comprehensive Clinical Guide. None. Springer, 141-146, 2024.
- Choi MK, Mehta P, Rushakoff R. Novel Approaches to Inpatient Diabetes Consultation. In: Inpatient Diabetes: A Comprehensive Clinical Guide. None. None, None, 2022.
- Mehta P, Rov-Ikpah E, Rushakoff R. Hypoglycemia in Hospitalized Patients with Diabetes. In: Inpatient Diabetes: A Comprehensive Clinical Guide. None. None, None, 2022.
- Mehta P, Quandt Z, Rushakoff R. Case 21: Checkpoint Inhibitor–Induced Diabetes. In: Diabetes In Practice: Case Studies with Commentary. None. American Diabetes Association, None, 2021.
- Quandt Z, Mehta P, Tsai K, Hsiao V, Rushakoff R. Case 20: Partial β-Cell Destruction: An Atypical Case of Immune Checkpoint Inhibitor Diabetes. In: Diabetes In Practice: Case Studies with Commentary. None. American Diabetes Association, None, 2021.
Letters to the Editor
- Mehta PB, Rushakoff RJ. A Diabetes and COVID-19 Dilemma: Balancing Parents' Health & Children's Education. J Diabetes Sci Technol 14: 1129-1130, 2020.
Patient Reviews
CV information above last modified February 19, 2025